| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC10037 | 4μ8C Featured | 4μ8C is a potent and selective IRE1 Rnase inhibitor with IC50 of 76 nM. |
|
| DC7358 | APY29 Featured | APY29 is an allosteric modulator of IRE1α; inhibits IRE1α autophosphorylation (IC50 = 280 nM) and activates IRE1α RNase activity. |
|
| DC10544 | MKC3946 Featured | MKC3946 is a potent and soluble IRE1α inhibitor, used for cancer research. |
|
| DC8413 | STF-083010 Featured | STF-083010 is a specific IRE1α endonuclease inhibitor. |
|
| DC48263 | IRE1α kinase-IN-6 | IRE1α kinase-IN-6 is a potent IRE1α inhibitor with an IC50 value of 4.4 nM. |
|
| DC70125 | GSK2850163 | A novel potent IRE1α-selective kinase inhibitor that inhibits both the kinase and RNase activities of IRE1α with IC50 of 20 nM and 200 nM, respectively; binds to pIRE1α and inhibits XBP 1 splicing; only weakly inhibits Ron (IC50= 4.4 uM) and FGFR1 V561M (IC50=17 uM) in a panel of 284 kinases. |
|
| DC71145 | KIRA9 | KIRA9 is a potent IRE1 inhibitor (IC50=4.8 μM in INS-1 cells). KIRA9 is able to fully engage the ATP-binding site of IRE1α. KIRA9 can block ER-localized mRNA decay and apoptosis. |
|
| DC71403 | PAIR2 | PAIR2 is a potent and selective partial antagonist of IRE1α RNase. PAIR2 can completely occupy IRE1α’s ATP-binding site in cells and block the ability of a potent KIRA to inhibit XBP1 splicing. |
|
| DC73837 | D-F07 | D-F07 is a novel fluorescent, covalent IRE-1 inhibitor, potently inhibits XBP-1s expression in MM cells. |
|
| DC73838 | PAIR1 | PAIR1 is a partial antagonist of IRE1α RNase (PAIR) that fully engage IRE1α's kinase domain (Ki=220 nM) but only partially inhibit its RNase activity. |
|
| DC73839 | TC-D-F07 | TC-D-F07 is a novel prodrug of the covalent IRE-1 inhibitor D-F07, inhibits IRE-1/XBP-1s pathway in cancer cells. |
|
